Syensqo SA
XBRU:SYENS
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
67.83
105.32
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one SYENS stock under the Base Case scenario is 115.61 EUR. Compared to the current market price of 70.17 EUR, Syensqo SA is Undervalued by 39%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Syensqo SA
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for SYENS cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
Syensqo SA
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Syensqo SA stands at the forefront of the biotechnology sector, driven by a vision to revolutionize disease treatment through advanced therapeutic solutions. Founded in the heart of an innovation hub, the company specializes in developing cutting-edge synthetic biology applications aimed at enhancing drug efficacy and reducing side effects. With a dynamic pipeline populated by promising drug candidates in various stages of clinical trials, Syensqo is harnessing the power of gene editing and novel delivery systems, creating a compelling narrative of growth and potential. Its strategic partnerships with leading research institutions and pharmaceutical companies underscore a commitment to colla...
Syensqo SA stands at the forefront of the biotechnology sector, driven by a vision to revolutionize disease treatment through advanced therapeutic solutions. Founded in the heart of an innovation hub, the company specializes in developing cutting-edge synthetic biology applications aimed at enhancing drug efficacy and reducing side effects. With a dynamic pipeline populated by promising drug candidates in various stages of clinical trials, Syensqo is harnessing the power of gene editing and novel delivery systems, creating a compelling narrative of growth and potential. Its strategic partnerships with leading research institutions and pharmaceutical companies underscore a commitment to collaboration and innovation, positioning Syensqo as a promising player in an ever-evolving market.
For investors, Syensqo SA embodies both opportunity and sustainability. The company’s robust intellectual property portfolio not only protects its innovations but also provides a competitive edge in emerging markets. With a dedicated team of scientists and industry veterans at the helm, Syensqo is primed to navigate the complexities of regulatory landscapes while leveraging data-driven insights to guide decision-making. As the global demand for effective healthcare solutions escalates, Syensqo's commitment to sustainable practices and ethical drug development resonates strongly with socially conscious investors. By investing in Syensqo, stakeholders are not only placing their capital in a high-growth venture but also participating in a transformative journey toward groundbreaking healthcare advancements.
As of my last update in October 2023, Syensqo SA is not a widely recognized company in public databases, so I'm unable to provide specific details about its core business segments. If Syensqo SA is a private or less-known entity, public information may be limited.
However, if you can provide more context about the company, such as its industry, target market, or any specific products and services it offers, I can help you analyze potential business segments based on that information. Additionally, if there are any strategic objectives or areas of focus for Syensqo SA, that would also help in identifying its core business segments.
To identify the unique competitive advantages of Syensqo SA over its rivals, we would typically need to analyze several key aspects of the company, including its business model, market position, resources, capabilities, and external factors. Here are some general competitive advantages that a company like Syensqo SA might have:
-
Technology and Innovation: If Syensqo SA has developed proprietary technology or innovative solutions that improve efficiency, reduce costs, or enhance customer experience, this can be a significant competitive edge.
-
Strong Brand Reputation: A well-established brand that is recognized for quality, reliability, or customer service can differentiate Syensqo SA from competitors.
-
Skilled Workforce: Having a talented and experienced team can lead to better decision-making, superior service delivery, and innovation, which may not be easily replicated by competitors.
-
Customer Relationships: Strong relationships with customers can lead to higher retention rates and loyalty. Unique insights from long-term partnerships may also inform product development and marketing strategies.
-
Operational Efficiency: Superior supply chain management or production processes can help reduce costs and improve margins, giving Syensqo SA a pricing advantage.
-
Niche Market Focus: If Syensqo SA targets a specific market segment that is under-served or has unique needs, it can position itself as the go-to provider for that particular audience.
-
Exclusive Partnerships or Supply Agreements: Collaborations with key players or exclusive supplier agreements can restrict competitors’ access to critical resources or markets.
-
Regulatory or Market Barriers: If Syensqo SA operates in a regulated industry, understanding and adeptly navigating these regulations can provide a competitive barrier for new entrants.
-
Sustainability Practices: A commitment to environmental sustainability can attract environmentally conscious consumers and differentiate the brand from less responsible competitors.
-
Financial Stability: Strong financial health enables investment in growth initiatives, resilience in downturns, and the ability to endure competitive pressures.
To provide a more tailored analysis, specific information regarding Syensqo SA’s industry context, market placement, and strategic initiatives would be necessary.
To assess the risks and challenges Syensqo SA might face, we can consider various factors that affect businesses in general along with industry-specific dynamics. Without specific details about Syensqo SA's business model, industry, and operational context, here are some potential risks and challenges they might encounter:
-
Market Competition: An increase in competition can erode market share and pricing power. If competitors adopt aggressive pricing strategies or enhance their offerings, it can challenge Syensqo's market position.
-
Regulatory Challenges: Compliance with industry regulations can be a significant hurdle. Changes in regulations or increased scrutiny can impact operational costs and business practices.
-
Technological Advances: The rapid pace of technological innovation can render existing products or services obsolete. Syensqo may need to invest in R&D to keep up with industry trends and shifting consumer preferences.
-
Supply Chain Disruptions: Global events, such as pandemics, geopolitical tensions, or natural disasters, can disrupt supply chains, affecting the availability of materials or products.
-
Economic Factors: Fluctuations in economic conditions, such as recession, inflation, or changes in consumer spending, can impact demand for Syensqo’s offerings.
-
Talent Acquisition and Retention: Attracting and retaining skilled workers in a competitive labor market can pose challenges. This includes the need for ongoing training and development in response to evolving technologies.
-
Cybersecurity Threats: Increased reliance on digital systems exposes the company to cybersecurity risks. Data breaches or cyberattacks could lead to significant financial and reputational damage.
-
Financial Risks: Fluctuations in interest rates, currency volatility, or access to financing may affect the company’s financial stability and growth prospects.
-
Environmental and Social Challenges: Companies are increasingly held accountable for their environmental impact and social responsibility. Failing to meet stakeholder expectations in these areas can result in reputational risks.
-
Customer Expectations: As consumer preferences evolve rapidly, Syensqo must stay attuned to these changes and be agile in its strategy and execution.
To better understand the specific risks Syensqo SA might face, it would be essential to analyze their industry context, market position, and recent performance indicators. Conducting a SWOT analysis (Strengths, Weaknesses, Opportunities, Threats) could provide more tailored insights into their risk landscape.
Revenue & Expenses Breakdown
Syensqo SA
Balance Sheet Decomposition
Syensqo SA
Current Assets | 3.3B |
Cash & Short-Term Investments | 707m |
Receivables | 1.3B |
Other Current Assets | 1.3B |
Non-Current Assets | 8.8B |
Long-Term Investments | 327m |
PP&E | 3.8B |
Intangibles | 4.1B |
Other Non-Current Assets | 582m |
Current Liabilities | 1.9B |
Accounts Payable | 885m |
Other Current Liabilities | 998m |
Non-Current Liabilities | 2.9B |
Long-Term Debt | 1.7B |
Other Non-Current Liabilities | 1.2B |
Earnings Waterfall
Syensqo SA
Revenue
|
8.5B
EUR
|
Cost of Revenue
|
-5.6B
EUR
|
Gross Profit
|
2.8B
EUR
|
Operating Expenses
|
-2.2B
EUR
|
Operating Income
|
658m
EUR
|
Other Expenses
|
-637m
EUR
|
Net Income
|
21m
EUR
|
Free Cash Flow Analysis
Syensqo SA
EUR | |
Free Cash Flow | EUR |
In Q3 2024, Syensqo returned to growth with net sales reaching €1.6 billion, supported by double-digit revenue increases in Composite Materials and Novecare. Underlying EBITDA held steady at €374 million, with an EBITDA margin improvement to 22.9%. The company has initiated a €300 million share buyback to enhance shareholder value. Despite challenges from the Boeing strike, which could impact 60% of sales, the midterm outlook remains positive, projecting continued volume growth. For Q4, EBITDA is expected to decline by about 20% sequentially, largely due to the strike's effects, yet long-term demand across sectors is promising.
What is Earnings Call?
SYENS Profitability Score
Profitability Due Diligence
Syensqo SA's profitability score is 46/100. The higher the profitability score, the more profitable the company is.
Score
Syensqo SA's profitability score is 46/100. The higher the profitability score, the more profitable the company is.
SYENS Solvency Score
Solvency Due Diligence
Syensqo SA's solvency score is 59/100. The higher the solvency score, the more solvent the company is.
Score
Syensqo SA's solvency score is 59/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SYENS Price Targets Summary
Syensqo SA
According to Wall Street analysts, the average 1-year price target for SYENS is 96.7 EUR with a low forecast of 66.66 EUR and a high forecast of 128.1 EUR.
Dividends
Current shareholder yield for SYENS is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
SYENS Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Syensqo SA is a BE-based company operating in Chemicals industry. The company is headquartered in Brussels, Bruxelles-Capitale. The company went IPO on 2023-12-11. Syensqo SA is a Belgium-based, Chemical company. The firm provides solutions across specialty polymers, composite materials, specialty formulations and bio-circular chemistries to assist its customers in identifying, developing, and manufacturing of sustainable solutions. The company is organized into two divisions: Materials which consists of performance in polymers platform coupled with a composites business mainly serving automotive, aerospace, and electronics markets; Consumer and Resources providing specialty solutions to consumer focused on end markets such as Argo, Personal Care, Food, etc.
Contact
IPO
Employees
Officers
The intrinsic value of one SYENS stock under the Base Case scenario is 115.61 EUR.
Compared to the current market price of 70.17 EUR, Syensqo SA is Undervalued by 39%.